Uracle Co., Ltd. (KOSDAQ:088340)

Revance Therapeutics Statistics

Total Valuation

Uracle has a market cap or net worth of KRW 70.20 billion. The enterprise value is 54.59 billion.

Market Cap	70.20B
Enterprise Value	54.59B

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Uracle has 3.92 million shares outstanding. The number of shares has increased by 5.70% in one year.

Current Share Class	3.92M
Shares Outstanding	3.92M
Shares Change (YoY)	+5.70%
Shares Change (QoQ)	-7.63%
Owned by Insiders (%)	20.98%
Owned by Institutions (%)	5.06%
Float	2.47M

Valuation Ratios

The trailing PE ratio is 57.31.

PE Ratio	57.31
Forward PE	n/a
PS Ratio	1.46
PB Ratio	2.81
P/TBV Ratio	3.05
P/FCF Ratio	29.21
P/OCF Ratio	25.08
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 26.17, with an EV/FCF ratio of 22.72.

EV / Earnings	44.22
EV / Sales	1.13
EV / EBITDA	26.17
EV / EBIT	58.61
EV / FCF	22.72

Financial Position

The company has a current ratio of 3.67, with a Debt / Equity ratio of 0.04.

Current Ratio	3.67
Quick Ratio	2.55
Debt / Equity	0.04
Debt / EBITDA	0.46
Debt / FCF	0.40
Interest Coverage	11.33

Financial Efficiency

Return on equity (ROE) is 5.96% and return on invested capital (ROIC) is 2.61%.

Return on Equity (ROE)	5.96%
Return on Assets (ROA)	1.76%
Return on Invested Capital (ROIC)	2.61%
Return on Capital Employed (ROCE)	3.07%
Revenue Per Employee	197.46M
Profits Per Employee	5.06M
Employee Count	244
Asset Turnover	1.46
Inventory Turnover	56.33

Taxes

In the past 12 months, Uracle has paid 109.66 million in taxes.

Income Tax	109.66M
Effective Tax Rate	8.16%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	21,445.60
200-Day Moving Average	15,838.25
Relative Strength Index (RSI)	36.12
Average Volume (20 Days)	187,433

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Uracle had revenue of KRW 48.18 billion and earned 1.23 billion in profits. Earnings per share was 312.17.

Revenue	48.18B
Gross Profit	12.23B
Operating Income	931.35M
Pretax Income	1.34B
Net Income	1.23B
EBITDA	2.09B
EBIT	931.35M
Earnings Per Share (EPS)	312.17

Balance Sheet

The company has 16.57 billion in cash and 963.44 million in debt, giving a net cash position of 15.61 billion or 3,978.21 per share.

Cash & Cash Equivalents	16.57B
Total Debt	963.44M
Net Cash	15.61B
Net Cash Per Share	3,978.21
Equity (Book Value)	24.99B
Book Value Per Share	6,413.83
Working Capital	23.43B

Cash Flow

In the last 12 months, operating cash flow was 2.80 billion and capital expenditures -396.46 million, giving a free cash flow of 2.40 billion.

Operating Cash Flow	2.80B
Capital Expenditures	-396.46M
Free Cash Flow	2.40B
FCF Per Share	612.37

Margins

Gross margin is 25.37%, with operating and profit margins of 1.93% and 2.56%.

Gross Margin	25.37%
Operating Margin	1.93%
Pretax Margin	2.79%
Profit Margin	2.56%
EBITDA Margin	4.33%
EBIT Margin	1.93%
FCF Margin	4.99%

Dividends & Yields

This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 0.56%.

Dividend Per Share	100.00
Dividend Yield	0.56%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-5.70%
Shareholder Yield	-5.16%
Earnings Yield	1.76%
FCF Yield	3.42%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Uracle has an Altman Z-Score of 4.54 and a Piotroski F-Score of 5.

Altman Z-Score	4.54
Piotroski F-Score	5